Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab + Prednisolone in Warm AIHA
NCT01134432Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Mar 2005
- Primary completion
- Jul 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in warm autoimmune hemolytic anemia (wAIHA), sponsored by Rigshospitalet. Started Mar 2005; status: completed.
02
Drugs
rituximab
03
Conditions
warm autoimmune hemolytic anemia (wAIHA)
Beyond the preview
Go deeper on NCT01134432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01134432.